Determinants of Response to Sequential Pembrolizumab with Trastuzumab Plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial.
Clinical cancer research an official journal of the American Association for Cancer Research（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined